Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Hahn

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
BMC Cancer|April 16, 2011
Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3εSven-T Liffers, Abdelouahid Maghnouj, Johanna B Munding, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Evaluation of the 4q32-34 locus in European familial pancreatic cancerJulie Earl, Li Yan, Louis J Vitone, et al.
Journal of Proteome Research|August 29, 2009
Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validationBarbara Sitek, Bence Sipos, Ibrahim Alkatout, et al.
Molecular Oncology|August 21, 2023
Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenograftsTimm M Reissig, Swetlana Ladigan-Badura, Anja Steinberg, et al.
Clinical Chemistry|August 23, 2008
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissuesAnna E Szafranska, Martina Doleshal, Hayward S Edmunds, et al.
Journal of the National Cancer Institute|February 6, 2003
BRCA2 germline mutations in familial pancreatic carcinomaStephan A Hahn, Bill Greenhalf, Ian Ellis, et al.
Oncogene|January 27, 2022
De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancerSabrina Steiner, Gitta M Seleznik, Theresia Reding, et al.
Gastroenterology|March 15, 2005
HNPCC-associated small bowel cancer: clinical and molecular characteristicsKarsten Schulmann, Frank E Brasch, Erdmute Kunstmann, et al.
International Journal of Cancer|June 30, 2020
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaXin Zhang, Tim Zegar, Tim Weiser, et al.
Gut|January 21, 2015
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signallingBo Kong, Weiwei Wu, Tao Cheng, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
BMC Cancer|April 16, 2011
Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3εSven-T Liffers, Abdelouahid Maghnouj, Johanna B Munding, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Evaluation of the 4q32-34 locus in European familial pancreatic cancerJulie Earl, Li Yan, Louis J Vitone, et al.
Journal of Proteome Research|August 29, 2009
Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validationBarbara Sitek, Bence Sipos, Ibrahim Alkatout, et al.
Molecular Oncology|August 21, 2023
Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenograftsTimm M Reissig, Swetlana Ladigan-Badura, Anja Steinberg, et al.
Clinical Chemistry|August 23, 2008
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissuesAnna E Szafranska, Martina Doleshal, Hayward S Edmunds, et al.
Journal of the National Cancer Institute|February 6, 2003
BRCA2 germline mutations in familial pancreatic carcinomaStephan A Hahn, Bill Greenhalf, Ian Ellis, et al.
Oncogene|January 27, 2022
De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancerSabrina Steiner, Gitta M Seleznik, Theresia Reding, et al.
Gastroenterology|March 15, 2005
HNPCC-associated small bowel cancer: clinical and molecular characteristicsKarsten Schulmann, Frank E Brasch, Erdmute Kunstmann, et al.
International Journal of Cancer|June 30, 2020
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaXin Zhang, Tim Zegar, Tim Weiser, et al.
Gut|January 21, 2015
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signallingBo Kong, Weiwei Wu, Tao Cheng, et al.
Pageof 9